Trial reportDrug and alcohol dependence2026
Time-varying mediated effects of the nicotine patch on smoking before and after a quit attempt when it is added to varenicline and counseling.
Trial report in Drug and alcohol dependence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEven with evidence-based treatment, most people who try to quit smoking return to regular smoking within weeks. Mediation analyses simultaneously test hypotheses about how treatments affect possible smoking determinants and how these determinants may influence smoking risk. Such evidence may inform treatment enhancement.
objectivesConduct secondary analyses that assess the extent to which: a) active vs. placebo nicotine patch used in conjunction with varenicline and counseling affect candidate mediators in the peri-cession period, b) candidate mediators predict next-day smoking, and c) treatment effects on next-day smoking are mediated via candidate mediators.
methodsTime-varying mediation models (TVMM) were fit to ecological momentary assessment data collected nightly from 1202 adults motivated to quit smoking in the 2 weeks preceding and 2 weeks following the target date to quit smoking in a placebo-controlled, double-blinded randomized controlled trial of adjuvant nicotine patch therapy used with varenicline and individual counseling.
resultsAnalyses confirmed the predictive value of hypothesized mediators (cravings to smoke, nicotine withdrawal symptoms, reduced positive affect, and low quitting confidence) on next-day smoking risk, but also found that only positive affect mediated active (vs. placebo) patch effects on next-day abstinence 3-9 days after a target quit day. DISCUSSION: Adding nicotine patches to varenicline and counseling improves positive affect in ways that predict lower next-day smoking risk in the first days of attempts to quit smoking but does not significantly improve withdrawal management or sustain confidence in quitting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.